These findings was similar to Légaré and Liu et al.’s reports in breast cancer and ovarian cancer9,10, which demonstrated that dysregulation of SPEN was significantly involved in the development of NPC, suggesting that it plays a potential tumor metastasis promoter in NPC. The gene discussed is SPEN; the disease is nasopharyngeal carcinoma.